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Abstract 
The genetic basis of congenital heart disease remains unknown in most of the cases. Recently, a novel mouse model shed new light 
on the role of CCN1/CYR61, a matricellular regulatory factor, in cardiac morphogenesis. In a candidate gene approach, we analyzed a 
cohort of 143 patients with atrial septal defects (ASD) by sequencing the coding exons of CCN1. In addition to three frequent 
polymorphisms, we identified an extremely rare novel heterozygous missense mutation (c.139C>T; p.R47W) in one patient with 
severe ASD. The mutation leads to an exchange of residues with quite different properties in a highly conserved position of the N-
terminal insulin-like growth factor binding protein (IGFBP) module. Further bioinformatic analysis, exclusion of known ASD 
disease genes as well as the exclusion of the mutation in a very high number of ethnically matched controls (more than 1000 
individuals) and in public genetic databases indicates that the p.R47W variant is a probable disease-associated mutation. The report 
about ASD in mice in heterozygous Ccn1 +/- animals strongly supports this notion. Our study is the first to suggest a relationship 
between a probable CCN1 mutation and ASD. Our purpose here was to draw attention to CCN1, a gene that we believe may be 
important for genetic analysis in patients with congenital heart disease. 
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Introduction 
Congenital heart disease (CHD) is the most common birth defect in humans. The etiology for most patients is unknown. 
Cardiogenesis is complex and appears highly susceptible to perturbations resulting in heart malformations [1, 2]. Among the most 
sensitive cardiac structures are the atrial and ventricular septa. Numerous advances in understanding the molecular pathways and 
genes involved in septal defects have been published in the past few years [1, 2]. Single gene mutations were identified as heritable 
risk factors for atrial septal defects (ASD) in a number of patients (as reviewed by us in Posch et al. [3]). Various mutations in 
transcription factors and sarcomeric genes were described in different studies [3]. We have analyzed different genes involved in the 
pathogenesis of CHDs and could identify mutations in ASD patients [4, 5, 6]. 
The CCN protein family is a novel class of signal modulators named after three prototypical members, cysteine-rich 
angiogenic inducer 61 (Cyr61; CCN1), connective tissue growth factor (CTGF; CCN2), and nephroblastoma overexpressed protein 
(Nov; CCN3) [7]. Matricellular CCN proteins are regulatory factors involved in cell signalling participating in various crucial 
biological processes like cell differentiation, adhesion, and apoptosis [7]. A mouse model shed new light on the role of CCN proteins 
in cardiac valvuloseptal morphogenesis: Mo and Lau described the Ccn1-null mouse showing severe septal defects with complete 
penetrance [8]. Therefore, CCN1 was considered a promising candidate gene for ASD in man. 
 
Materials and Methods 
We enrolled 143 patients (most of them of Caucasian origin) after informed consent was obtained. All of them underwent extensive 
non-invasive and invasive cardiovascular evaluation. The study cohort consisted of unrelated patients with atrial septal defect (ASD), 
nearly all sporadic cases. The vast majority (n=134; 94%) had an isolated ostium secundum atrial septal defect (ASD II). Only 9 
patients (6%) had ASD II with concomitant minor CHD (including aortic coarctation, persistent ductus arteriosus, and partial 
anomalous venous return). The first control group of 300 unrelated Caucasians had no CHD as shown by echocardiography. The 
second control group - matched to the ethnicity of the identified patient - comprised 1015 samples randomly selected from a group of 
5100 unrelated adults, residents of the Ashanti region in Ghana. The study complies with the 1964 Declaration of Helsinki. The 
research protocol has been approved by the locally appointed ethics committees in Berlin and Kumasi and informed consent has been 
obtained from the enrolled subjects. 
We sequenced the five exons of CCN1/CYR61 (Genbank accession number NM_001554) using PCR and ABI technology 
(Applied Biosystems, Darmstadt, Germany). After identification of variants, allele frequencies were assessed in controls using 
restriction endonuclease digestion (Ava II) or using HybProbe chemistry and a LightCycler (Roche, Mannheim, Germany). The 
significance of the identified variant p.R47W was assessed by considering the conservation of the affected amino acid, the nature and 
location of the change, its rarity assessed in own controls and population-based datasets, and the possible impact of the amino acid 
substitution by five different mutation prediction tools (Mutation Taster [9], MutPred [10], SIFT [11], Polyphen2 [12], and SNAP 
[13]). We analyzed p.R47W by checking two large population-based databases, dbSNP (release 138 at 
http://www.ncbi.nlm.nih.gov/snp) and the Exome Sequencing Project (ESP6500SI-V2 dataset) of the National Heart, Lung and 
Blood Institute (http://evs.gs.washington.edu/EVS/ [14]). 
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Results 
In total, we found one novel and three known variants in the CCN1 gene (Fig. 1c). Three of these variants (p.L192L, p.S316C, and 
p.R334W) were identified as being polymorphisms because they were found in various frequencies in both cohorts, patients and 
Caucasian controls, and were registered in dbSNP. In contrast, we identified the novel heterozygous c.139C>T missense variant in 
exon 2 (Fig. 1b) in one patient only. The mutation leads to an exchange of the positively charged residue arginine to the aromatic 
hydrophobic residue tryptophane at codon 47 (p.R47W). We did not find this variant in dbSNP and the ESP dataset which points to 
the novelty and extreme rarity of p.R47W. It is located in module 1 of the CCN1 protein, namely the N-terminal insulin-like growth 
factor binding protein (IGFBP) domain, very closely to the “IGFBP motif” (Fig. 1a). The affected amino acid is highly conserved in 
orthologs of 14 vertebrates (ranging from chimp to zebrafish) and in paralogs of the human IGFBP isoforms 1-4 (Fig. 1a). While 
only PolyPhen2 predicted p.R47W as neutral, the other four mutation prediction tools predicted the variant as deleterious. The patient 
with the p.R47W mutation was of West African origin. Because of the high degree of genetic variability found in Africans, we chose 
controls with the same ethnic origin, a cohort of 1015 unrelated individuals from West Africa. All 2030 control alleles were negative 
for the mutation (as well as 600 alleles from the Caucasian controls without CHD). The 4406 alleles of African American origin in 
the ESP dataset did also not show this mutation. Further, the disease genes GATA4 and NKX2.5 that are known to cause non-
syndromic ASD, were excluded as cause of the disease in this patient as described previously [4]. 
The male black patient aged 36 years was admitted to the hospital because of exertional dyspnoea. Physical examination 
revealed no signs of cyanosis, pulmonary congestion, or peripheral edema. The ECG confirmed sinus rhythm and showed an 
incomplete right bundle branch block. Furthermore, a crochetage pattern of the R wave was present in the inferior limb leads (Fig. 
2a). The transthoracic echocardiography (TTE) revealed severe enlarged right atrium and ventricle. The function of both ventricles 
was maintained. A significant ASD (3.7 cm in diameter) with a large left-right shunt was demonstrated by TTE (Fig. 2b). Cardiac 
catheterization revealed a pulmonary artery blood flow relative to systemic blood flow (Qp/Qs) of 5:1. Since there was only a 
rudimental atrial septum, the finding was considered as a common atrium. The defect was surgically closed with a Gore-Tex patch. 
Unfortunately, we had no access to his family. 
 
Discussion 
To our knowledge, this report is the first to suggest a relationship between a genetic variant in CCN1, a growth-factor inducible 
immediate-early gene, and a human disease (see Online Mendelian Inheritance in Man OMIM No. *602369). Although the patient´s 
family was not available, there are numerous findings supporting the notion that the p.R47W variant is a probable disease-associated 
mutation rather than a rare polymorphism.  
The extreme rarity of the mutation in the patient cohort, as also reported for the other ASD associated variants [3], and the 
exclusion of this variant in a very high number of ethnically well matched controls (our own 1015 controls and 2203 African 
Americans from the ESP dataset) are important points, as well as the exclusion of known ASD disease genes. The mutation leads to 
an exchange of residues with quite different properties in a highly conserved position of the IGFBP module harboring the important 
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“IGFBP motif” found in all IGFBPs and CCN proteins [15] suggesting a disturbed protein folding (strengthened by special 
bioinformatic tools). This motif is the central element of the “palm-like” protein structure, around which a polypeptide chain is bent, 
forming a disulfide ladder and assuring a proper spatial relationship between the key IGF-binding residues in that domain [16]. 
Interestingly, Buckway et al. showed by site-directed mutagenesis that single missense mutations in this N-terminal domain, adjacent 
to codon 47, were sufficient to weaken the IGF binding of IGFBP3 which shares high homology with CCN1 [17]. Therefore, it seems 
highly probable that the p.R47W mutation also may alter the IGF binding of this domain, thus modulating IGF´s biological effects in 
embryonic development. Indeed, IGFs are potent cell survival signals (in combination with IGFBPs as regulators of this function) 
influencing apoptosis, one of the key mechanisms for sculpting embryonic tissue [18]. Furthermore, Zhu at al. reported a previously 
unknown function of IGFBP-4 as a cardiogenic growth factor by knockdown of the homologous IGFBP-4 in Xenopus embryos 
which resulted in cardiac defects [19]. 
Limitations of our study are the lack of cosegregation and of biochemical data concerning an effect of the mutation. Indeed, 
it is most likely that the majority of patients with ASD have a complex, multifactorial aetiology [3]. But one should also note that the 
cardiac phenotype most frequently seen in published mutation carriers are ASDs [3]. It may be possible that the p.R47W variant is 
unrelated to the disease. But our genetic data and pathophysiologic conclusions in combination with the Ccn1 mouse model fit 
together quite well and contradict this notion. Indeed, one of the strongest arguments supporting our data is the remarkable 
observation by Mo and Lau that haploinsuffiency for Ccn1 (heterozygous +/- mice) also resulted in delayed formation of the 
ventricular septum in the mouse embryo and persistent ASD in 20% of adult mice [8]. In these animals, Ccn1 haploinsuffiency 
caused precocious apoptosis in the atrial junction of the cushion tissue and impaired gelatinase activities in the muscular component 
of the interventricular septum, when fusion between the endocardial cushion tissue and the atrial and ventricular septa occurred [8]. 
Clearly, deficiency in matrix signaling by CCN proteins could lead to autosomal dominant septal defects, identifying heterozygous 
Ccn1 mice as a genetic model for ASD. 
In conclusion, using a translational approach we identified the first probable mutation (p.R47W) in a patient with large ASD 
linking CCN1, an important factor in embryogenesis and subsequent development, to human pathology. Our results underscore close 
homology between the mouse model and human disease. Further studies are necessary to elucidate the mechanism of how this 
mutation contributes to septal defects. 
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Figure  legends: 
 
Fig. 1 Genetic data of the p.R47W patient 
a) Amino acid sequence alignment of residues 44-56 of the IGFBP domain of CCN1 demonstrating very high conservation. Mutated 
codon 47 is shaded. The “IGFBP motif” (GCGCCxxC) is boxed. Residues that are not conserved are shown in bold. 
b) Electropherogram of the heterozygous missense mutation c.139C>T. 
c) Localization of the detected variants (three SNPs and the p.R47W mutation) in the CCN1 gene/protein (shown by arrows). The 
upper panel shows the gene structure (exons as boxes, coding sequence shaded). The lower panel shows the protein structure (SP – 
signaling peptide, IGFBP – insulin-like growth factor binding protein domain, VWC – Von Willebrand factor domain, TSP-1 – 
thrombospondin-homology domain, CT - cysteine knot domain, AA – amino acid). 
  
Fig. 2 Clinical vignettes of the p.R47W patient 
a) ECG demonstrating an incomplete right bundle branch block and typical crochetage pattern of the R wave in the inferior leads II, 
III, and aVF. 
b) 2-D echocardiography revealing a large atrial septal defect (see arrowheads, modified parasternal long axis view). 
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